Login / Signup
Pembrolizumab and Ipilimumab as Second-Line Therapy for Advanced Melanoma.
Laura A Huppert
Adil I Daud
Published in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Keyphrases
</>
advanced non small cell lung cancer
skin cancer
epidermal growth factor receptor